Calming and Sleeping in Brazil

  • April 2015
  • -
  • Euromonitor International
  • -
  • 27 pages

In 2014 calming and sleeping increased by 7% in current value terms in Brazil, reaching BRL158 million. This performance was aligned with that registered in the review period, when the category grew by a CAGR of 8% in current value terms. The fast pace of life in large urban centres continued to drive sales growth. Traffic jams, crowded public transportation systems and urban violence contributed to a high level of stress amongst Brazilian metropolitan citizens. On the other hand, rising...

Euromonitor International's Calming and Sleeping in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Data Coverage:

market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

* Get a detailed picture of the Calming and Sleeping market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table Of Contents

Calming and Sleeping in Brazil
CALMING AND SLEEPING IN BRAZIL
Euromonitor International
April 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Calming and Sleeping: Value 2009-2014
Table 2 Sales of Calming and Sleeping: % Value Growth 2009-2014
Table 3 NBO Company Shares of Calming and Sleeping: % Value 2010-2014
Table 4 LBN Brand Shares of Calming and Sleeping: % Value 2011-2014
Table 5 Forecast Sales of Calming and Sleeping: Value 2014-2019
Table 6 Forecast Sales of Calming and Sleeping: % Value Growth 2014-2019
Boehringer Ingelheim Do Brasil Química E Farmacêutica Ltda in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 1 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Key Facts
Company Background
Production
Summary 2 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Production Statistics 2014
Competitive Positioning
Summary 3 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2014
Hypermarcas SA in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 4 Hypermarcas SA: Key Facts
Summary 5 Hypermarcas SA: Operational Indicators
Company Background
Production
Summary 6 Hypermarcas SA: Production Statistics 2014
Competitive Positioning
Summary 7 Hypermarcas SA: Competitive Position 2014
Executive Summary
Improper Self-medication Culture Restricts OTC Sales Growth in Brazil
New Anvisa Regulation Allows Interchangeability Between Similar Medications and Generics
Negative Media Hampers the Growth of Local Sports Nutrition Brands
Continued Investment in Private Label by Chemists/pharmacies
Brazil Witnesses A Slowdown in OTC Consumption During the 2014 Fifa World Cup
Key Trends and Developments
Improper Self-medication Culture Restricts OTC Sales Growth in Brazil
New Anvisa Regulation Allows Interchangeability Between Similar Medicines and Generics
Negative Media Hampers the Growth of Local Sports Nutrition Brands
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 8 Life Expectancy at Birth 2009-2014
Market Data
Table 9 Sales of Consumer Health by Category: Value 2009-2014
Table 10 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 11 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 12 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 13 Distribution of Consumer Health by Format: % Value 2009-2014
Table 14 Distribution of Consumer Health by Format and Category: % Value 2014
Table 15 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 8 Research Sources












View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • March 2015
  • by Global Data

PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 Summary Type 1 diabetes (T1D) is an autoimmune disease that permanently destroys beta cells of the pancreatic islet, which ...

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • February 2015
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2023 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

2015 Strategies for the US Clinical Chemistry and Immunodiagnostics Market

2015 Strategies for the US Clinical Chemistry and Immunodiagnostics Market

  • $ 7 500
  • Industry report
  • May 2015
  • by Venture Planning Group

"2015 Strategies for the US Clinical Chemistry and Immunodiagnostics Market" is a new strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic markets ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.